Home 2017
Archives
FDA Approves Keytruda for All Cancers With Genetic Biomarker
First medication sanctioned for any cancer, regardless of origin
APA: Americans Believe Tx Not Punishment Best for Opioid Crisis
Poll finds 58 percent for prioritizing access to treatment; 26 percent for more punishment
Even Small Amounts of Alcohol Can Affect Breast Cancer Risk
Small glass of wine each day can up odds of both premenopausal and postmenopausal breast cancer
Gender Confirmation Surgeries Up 20 Percent From 2015 to 2016
Rise attributed to more widespread insurance coverage, growing acceptance of transgender people
FDA Approves Actemra to Treat Giant Cell Arteritis
New indication provides the first FDA-approved therapy specific to this type of vasculitis
FDA OKs Kalydeco for Additional Mutations in Cystic Fibrosis
Decision based on results of laboratory testing and previous clinical trials
HRT Not Advised for Disease Prevention Post Menopause
Benefits of treatment don't outweigh the risks, U.S. Preventive Services Task Force reiterates
CDC: Slowing of Decline in Number of Uninsured Adults
Uninsured rate was 9 percent in 2016, compared with 9.1 percent in 2015
States Given Until 2022 to Meet Medicaid Standards of Care
Standards set in a 2014 rule aim to improve quality of care that disabled receive outside of institutions
FDA Warns of Amputation Risk Associated With Canagliflozin
Canagliflozin tied to a doubling of amputations of legs, feet, agency says
